Evaluation of HEArt invoLvement in Patients With FABRY Disease
Recruiting
Observational Study
Rare Diseases
Fabry Disease
Fabry Disease, Cardiac Variant
Hypertrophic Cardiomyopathy
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 650 (estimated)
- Sponsor
- Wuerzburg University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Fabry disease (genetically confirmed)
* Signed informed consent
* 18 years and older
Exclusion Criteria:
* No informed consent
* Withdrawal of informed consent
Contacts